RxDoctor Payments Data

Amin Herati, MD

Urology · Baltimore, MDNPI 1205153947

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $109,411 of the $159,729 with a category attached, or 68.5%. Teleflex LLC accounts for 83.8% of it on its own, with 25 other manufacturers making up the rest. Among urology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$159,729in general payments, 2019–2025

Across 390 payments — averaging $409.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$134K
  • Olympus America Inc.$7K
  • LINA Medical USA Inc$5K
  • Procept Biorobotics Corporation$3K
  • Neotract Inc.$3K
  • Boston Scientific$3K
  • plus $5K from 20 others

What the payments were for

  • Consulting fees$22,93814%
  • Speaking & faculty fees$109,41168%
  • Travel & lodging$15,21710%
  • Food & beverage$12,1638%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$159,729 in reported general payments places this provider in the 95th percentile of 274 urology providers in Maryland.

See all urology providers in Maryland

Medicare billing

Part B allowed, 2024
$126,328
Medicare patients
349
Services billed
944

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron23$33,258
Testosterone12$2,790
Tamsulosin Hcl148$2,493
Cabergoline22$1,374
Solifenacin Succinate25$1,098
Anastrozole41$1,061
Vardenafil Hcl12$894
Alfuzosin Hcl ErAlfuzosin Hcl25$816
Finasteride16$259
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim24$201
Oxybutynin Chloride ErOxybutynin Chloride19$200
Trospium Chloride13$15

Paid to pharmacies, not to this prescriber.

Other urology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →